Medtronic Inc (NYSE:MDT) | Aetna and Medtronic Collaborate to Help Members Take Better Control of Type 2 Diabetes

[Business Wire] – Beginning this month, Aetna and Medtronic, Inc. will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may . . . → Read More: Medtronic Inc (NYSE:MDT) | Aetna and Medtronic Collaborate to Help Members Take Better Control of Type 2 Diabetes Similar Articles: Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Xigduo™ (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes Company Update: Abbott Laboratories (NYSE:ABT) – Experience ″A Day in the Life″ of an Insulin-using Patient with Diabetes through Interactive Infographic This Top-Performing Stock is Tackling One of the World’s Deadliest Diseases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.